Metropolis Healthcare Limited

NSE METROPOLIS.NS

Metropolis Healthcare Limited Price to Sales Ratio (P/S) on February 07, 2025: 7.46

Metropolis Healthcare Limited Price to Sales Ratio (P/S) is 7.46 on February 07, 2025, a -4.14% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Metropolis Healthcare Limited 52-week high Price to Sales Ratio (P/S) is 9.66 on October 09, 2024, which is 29.42% above the current Price to Sales Ratio (P/S).
Metropolis Healthcare Limited 52-week low Price to Sales Ratio (P/S) is 6.99 on March 19, 2024, which is -6.34% below the current Price to Sales Ratio (P/S).
Metropolis Healthcare Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 8.33.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: METROPOLIS.NS

Metropolis Healthcare Limited

CEO	Mr. Surendran Chemmenkotil
IPO Date	April 15, 2019
Location	India
Headquarters	250-D, Udyog Bhavan
Employees	4,313
Sector	Healthcare
Industries Biotechnology Clinical Trials Dental Care Drugstores & Retail Pharmacies Medical Instruments Personal Care Pharmaceuticals Telehealth

Description

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.

Key trends

Past 5 years